1,200
Participants
Start Date
December 31, 2008
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
13 valent pneumococcal conjugate vaccine
Intramuscular injection of 0.5mL at visit 1 and visit 2 for group 1 and and visit 1 for groups 2, 3, and 4.
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Vienna
Pfizer Investigational Site, Cary
Pfizer Investigational Site, Marietta
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Clarksville
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Monroe
Pfizer Investigational Site, Saint Paul
Pfizer Investigational Site, Fargo
Pfizer Investigational Site, Bismarck
Pfizer Investigational Site, DeKalb
Pfizer Investigational Site, Benton
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Jonesboro
Pfizer Investigational Site, Fayetteville
Pfizer Investigational Site, Tulsa
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, South Jordan
Pfizer Investigational Site, Murray
Pfizer Investigational Site, Salt Lake City
Pfizer Investigational Site, Torrance
Pfizer Investigational Site, Loma Linda
Pfizer Investigational Site, Fountain Valley
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Louisville
Pfizer Investigational Site, Lebanon
Pfizer Investigational Site, Whitehouse Station
Pfizer Investigational Site, Galveston
Lead Sponsor
Pfizer
INDUSTRY